Due to the impact of KRAS being largely cell type-dependent [45,46,47], the analysis of oncogenic mutations in non-transformed acinar cells is critical to characterize the precise mechanism of tumor initiation and possibly identify targetable processes to prevent cancer onset. This evidence concerns the gene KRAS and neoplasm.